CompletedNo phase
Assessment of Revascularization in Plantar Foot of Diabetic Patients Pre and Post Angioplasty Using Spatial Frequency Domain Imaging
Key facts
- Who runs it
- Singapore General Hospital
- Where
- Singapore1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Completed
- People taking part
- 15 people enrolled
- Started
- 2 Oct 2024
- Ended
- 31 Dec 2025
- Type of study
- Interventional
- Treatments tested
- SFDI
- Record updated
- 18 August 2026
Who can take part
- Age
- 21 years to 99 years
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 5 criteriaShow less
Who can take part
- Patients of age 21 years and above with diabetes and undergoing lower limb arterial angioplasty
- Willingness to participate in the study and undergo foot physiological assessments using SFDI
Who cannot take part
- Any medical condition which makes the candidate an inappropriate subject for study participation, in the investigator's judgment
- Mentally incompetent, younger than 21 years of age, prisoners, pregnant or breastfeeding women
- Patients unable to provide informed consent
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
To explore the usefulness of SFDI in the assessment of revascularization pre and post intervention
The group in the trial
- SFDI ImagingTreatment being tested
SFDI Imaging performed on both ipsilateral and contralateral foot. Imaging repeated on heel and pad regions of foot.
Treatment: SFDI
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- Assessment of Revascularization in Plantar Foot of Diabetic Mellitus Patients Pre and Post Angioplasty Using Spatial Frequency Domain Imaging
- Record updated
- 18 August 2026